Antibiotic Prophylaxis for Percutaneous Endoscopic Gastrostomy in Children: A Randomised Controlled Trial
Topic overview
Randomized controlled trial demonstrates that single-dose co-amoxiclav prophylaxis before PEG placement in children significantly reduces overall infection rates (13.6% vs 40%) and shortens hospital stays. While individual wound and systemic infection rates showed trends favoring prophylaxis, the combined benefit supports routine antibiotic use for pediatric PEG procedures.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Antibiotic Prophylaxis for Percutaneous Endoscopic Gastrostomy in Children: A Randomised Controlled Trial. GlobalCastMD Medical Library. 2021-01-08. https://library.globalcastmd.com/article/3502
Comments